Indian pharma firms trail global peers in R&D, innovation, and talent metrics: FAST India-IIFL Securities
FAST India) in collaboration with IIFL Securities.
The largest disparity was observed in the number of publications per billion USD revenue, with global firms producing 8.4 times more publications than Indian firms, the report noted.
Global firms generated 5.6 times more patents and 8.4 times more publications per billion USD of revenue compared to Indian firms.
In terms of Research and Development (R&D) intensity, global firms outperformed Indian firms by a factor of 3.0, the report added.
The report also highlighted that Indian pharmaceutical companies are performing better in the patents-to-revenue parameter than in the publications-to-revenue parameter, with four Indian firms ranking among the top ten for patents by revenue.
Strategy
Succession Planning Masterclass
By — Nigel Penny, Global Strategy Advisor: NSP Strategy Facilitation Ltd.
Finance
Financial Reporting and Analytics
By — Dr. C.P. Gupta, Professor: Department of Finance and Business Economics, University of Delhi
Legal
Digital Personal Data Protection Act 2023
By — Gaurav Khera, Partner, Risk Advisory: Deloitte
Marketing
Digital Marketing Masterclass by Pam Moore
By — Pam Moore, Digital Transformation and Social Media Expert
Legal
Mastering M&A Deal Making
By — Ashwath Rau, Senior Partner- AZB & Partners
HR
Human Potential and the Future of Employment
By — Lynda Gratton, Prof. at London Business School, Speaker, Author, Global Thought Leader
Finance
AI and Generative AI for Finance
By — Hariom Tatsat, Vice President- Quantitative Analytics at Barclays
Astrol
